We seek licensing-in cooperation with external
partners to access innovative technology
platforms, drugs, or therapies.

By collaborating with industry-leading research
institutions, biotechnology companies, and
academia, we hope to obtain new therapies
and technology platforms that will generate
synergies with our pipeline and further expand
our product lines and R&D areas.

We leverage our company’s proprietary
technology and innovations to establish strong
cooperation with our partners by licensing out
our innovative drugs, enabling patients
worldwide to benefit from our R&D outcomes.

We work closely with our partners to ensure
successful cooperation and realize our
common interests.

We actively explore clinical collaborations with
other biopharmaceutical companies to jointly
develop combination therapies to achieve
synergies, providing patients with more
comprehensive and effective treatment
options.

We hope to deliver better therapies and make
greater advancements and breakthroughs in
the healthcare field to benefit more patients.